Marcel Horký

687 total citations
19 papers, 597 citations indexed

About

Marcel Horký is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marcel Horký has authored 19 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marcel Horký's work include Cancer-related Molecular Pathways (7 papers), Cell death mechanisms and regulation (5 papers) and DNA Repair Mechanisms (3 papers). Marcel Horký is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cell death mechanisms and regulation (5 papers) and DNA Repair Mechanisms (3 papers). Marcel Horký collaborates with scholars based in Czechia, Austria and Germany. Marcel Horký's co-authors include Józefa Węsierska‐Gądek, Marieta Gueorguieva, Karel Klepárnı́k, Jacek Wojciechowski, Bořivoj Vojtěšek, Marc Anton, Jiřı́ Vácha, Martin Trbušek, Miroslav Strnad and Stjepan Uldrijan and has published in prestigious journals such as Journal of Cell Science, Annals of the New York Academy of Sciences and International Journal of Cancer.

In The Last Decade

Marcel Horký

19 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Horký Czechia 13 350 292 101 70 67 19 597
Christopher M. Fife Australia 10 354 1.0× 171 0.6× 162 1.6× 76 1.1× 133 2.0× 14 699
N. V. Krakhmal Russia 8 208 0.6× 234 0.8× 88 0.9× 45 0.6× 84 1.3× 23 511
Jan Scicinski United States 16 425 1.2× 318 1.1× 46 0.5× 113 1.6× 86 1.3× 48 896
Lisheng Ge United States 14 274 0.8× 124 0.4× 58 0.6× 41 0.6× 25 0.4× 28 510
Bingchen Han United States 12 434 1.2× 342 1.2× 60 0.6× 82 1.2× 114 1.7× 16 767
Teng Ji China 16 347 1.0× 190 0.7× 62 0.6× 34 0.5× 32 0.5× 29 642
Babak Nami Canada 12 231 0.7× 246 0.8× 65 0.6× 53 0.8× 24 0.4× 17 530
Oleg Tikhomirov United States 13 404 1.2× 294 1.0× 54 0.5× 37 0.5× 60 0.9× 16 924
Leanne C. Sayles United States 12 567 1.6× 239 0.8× 53 0.5× 122 1.7× 42 0.6× 24 840
Jennifer Silvester Canada 11 361 1.0× 168 0.6× 153 1.5× 79 1.1× 31 0.5× 13 604

Countries citing papers authored by Marcel Horký

Since Specialization
Citations

This map shows the geographic impact of Marcel Horký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Horký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Horký more than expected).

Fields of papers citing papers by Marcel Horký

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Horký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Horký. The network helps show where Marcel Horký may publish in the future.

Co-authorship network of co-authors of Marcel Horký

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Horký. A scholar is included among the top collaborators of Marcel Horký based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Horký. Marcel Horký is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hebel, Tobias, Berthold Langguth, Martin Schecklmann, et al.. (2022). Rationale and study design of a trial to assess rTMS add-on value for the amelioration of negative symptoms of schizophrenia (RADOVAN). Contemporary Clinical Trials Communications. 26. 100891–100891. 3 indexed citations
2.
Węsierska‐Gądek, Józefa, et al.. (2005). Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.. PubMed. 56(5). 635–41. 29 indexed citations
3.
Węsierska‐Gądek, Józefa, Marieta Gueorguieva, & Marcel Horký. (2005). Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells. Molecular Cancer Therapeutics. 4(1). 113–124. 58 indexed citations
4.
Węsierska‐Gądek, Józefa, Marieta Gueorguieva, & Marcel Horký. (2004). Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.. PubMed. 55(5). 895–902. 41 indexed citations
5.
Horký, Marcel, et al.. (2004). Immunohistochemical detection of acetylation and phosphorylation of histone H3 in cervical smears.. PubMed. 69(1). 3–6. 15 indexed citations
6.
Klepárnı́k, Karel & Marcel Horký. (2003). Detection of DNA fragmentation in a single apoptotic cardiomyocyte by electrophoresis on a microfluidic device. Electrophoresis. 24(21). 3778–3783. 59 indexed citations
7.
Horký, Marcel, et al.. (2003). Induction of cell cycle arrest and apoptosis in human cervix carcinoma cells during therapy by cisplatin. Cancer Detection and Prevention. 27(6). 481–493. 15 indexed citations
8.
Wojciechowski, Jacek, Marcel Horký, Marieta Gueorguieva, & Józefa Węsierska‐Gądek. (2003). Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine‐induced apoptosis of human MCF‐7 breast cancer cells. International Journal of Cancer. 106(4). 486–495. 70 indexed citations
9.
Smrčka, Martin, et al.. (2003). The onset of apoptosis of neurons induced by ischemia-reperfusion injury is delayed by transient period of hypertension in rats.. Physiological Research. 117–122. 5 indexed citations
10.
Smrčka, Martin, et al.. (2003). The onset of apoptosis of neurons induced by ischemia-reperfusion injury is delayed by transient period of hypertension in rats.. PubMed. 52(1). 117–22. 4 indexed citations
11.
Dobšák, Petr, Jarmila Siègelovà, Jean‐Eric Wolf, et al.. (2002). Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model. Pathophysiology. 9(1). 27–32. 21 indexed citations
12.
Węsierska‐Gądek, Józefa, et al.. (2002). Escape of p53 protein from E6‐mediated degradation in HeLa cells after cisplatin therapy. International Journal of Cancer. 101(2). 128–136. 91 indexed citations
13.
Horký, Marcel, et al.. (2002). Nucleolus and Apoptosis. Annals of the New York Academy of Sciences. 973(1). 258–264. 44 indexed citations
14.
Horký, Marcel, et al.. (2002). Molecular biology of doxorubicin-induced cardiomyopathy.. PubMed. 7(1). 35–9. 16 indexed citations
15.
Uldrijan, Stjepan, et al.. (2001). Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases. Cellular and Molecular Life Sciences. 58(9). 1333–1339. 42 indexed citations
16.
Horký, Marcel, et al.. (2001). Segregation of nucleolar components coincides with caspase-3 activation in cisplatin-treated HeLa cells. Journal of Cell Science. 114(4). 663–670. 65 indexed citations
17.
Horký, Marcel, et al.. (2000). The role of tumour suppressors and viral oncoproteins in cervical carcinogenesis.. PubMed. 65(4). 275–8. 4 indexed citations
18.
Horký, Marcel, et al.. (1997). Different Onset of Nucleolar Activation in Endocardial Endothelial Cells and Cardiomyocytes Following Pressure Overload in Rat Heart. Journal of Molecular and Cellular Cardiology. 29(9). 2475–2481. 3 indexed citations
19.
Horký, Marcel, et al.. (1997). Induction of cell-cycle inhibitor p21 in rat ventricular myocytes during early postnatal transition from hyperplasia to hypertrophy.. PubMed. 46(3). 233–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher M. Fife Breakdown of academic impact, for papers by N. V. Krakhmal Breakdown of academic impact, for papers by Jan Scicinski Breakdown of academic impact, for papers by Lisheng Ge Breakdown of academic impact, for papers by Bingchen Han Breakdown of academic impact, for papers by Teng Ji Breakdown of academic impact, for papers by Babak Nami Breakdown of academic impact, for papers by Oleg Tikhomirov Breakdown of academic impact, for papers by Leanne C. Sayles Breakdown of academic impact, for papers by Jennifer Silvester
Rankless by CCL
2026